Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Thursday, October 28, 2021 1:18:34 PM
So 10%...15% or 20% would do it?...of course it would.
BUT YOU FAIL to acknowledge FDA was fully on board with Compassionate Use of Brilacidin after, and maybe before the end of the Clinical Trials...so since Drs requesting and receiving CU must report back to the FDA on impact... the FDA and IPIX know its impact of Brilacidin on the Critically Ill recipients of Brilacidin, which group has only a 5% survival rate...If 6 or 10 patients received Brilacidin via Compassionate Use and 3 or 5 survived...the question is ..." to what miracle would the FDA attribute an approximate 50% survival improvement?"
It's all speculation on my part (because Compassionate Use is not double-blinded)...but it should be noted that the FDA granting and encouraging (not stopping) Compassionate Use ... therefore, Compassionate Use results could be even more telling about Brilaicidin's attributes and efficacy...especially if the dosage was increased well beyond Clinical Trial protocol...
...all IMO...
We should learn a boatload in less than 7 trading days...
KNOW WHAT YOU OWN!
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM